PeptideWars covers peptide research, access, vendors, safety issues, and regulation. The material is for adults and is educational coverage only.
A running desk for what changed, what source said it, and what remains unproven. Regulation, access, safety, research, and vendors are kept in separate lanes.
Regulatory actions, access changes, clinical research, safety items, and sports eligibility notes.
A legal-first shortlist for peptide-related access, pharmacy verification, and vendor due diligence. This page does not recommend unapproved research peptides for human use.
Best starting point for authentic Eli Lilly medicines and official self-pay or pharmacy-service pathways for eligible patients. Useful when checking Zepbound or other Lilly access because it routes through manufacturer-backed pharmacy options rather than anonymous sellers.
ReviewNovo Nordisk's official pharmacy and savings channel for Novo GLP-1 medicines. Strong fit for people comparing legitimate Wegovy access, current savings terms, and prescription-based delivery options.
ReviewLarge telehealth platform focused on prescription weight-loss medication access, insurance checks, and ongoing provider support. Best reviewed for FDA-approved GLP-1 access; confirm membership fees, prescribing standards, and pharmacy fulfillment before using.
ReviewCombines clinical access with weight-management coaching and behavior support. Good candidate when the user wants a structured program around medication, not just a prescription transaction.
ReviewTelehealth weight-management program with clinician review, lab-related workflow, and GLP-1 access for qualifying patients. Review carefully for medication type, pharmacy source, renewal terms, and whether any compounded option is appropriate and lawful.
ReviewUseful for comparing prescription pricing, coupons, and available care pathways. Treat it as a cost and access research layer; still verify the prescriber, pharmacy, drug identity, and insurance implications.
ReviewNot a vendor, but essential before trusting any online pharmacy. Use NABP's Safe Site Search to check whether a pharmacy website is verified, accredited, or flagged as unsafe.
VerifyNot a consumer shopping page. Use it to confirm whether an outsourcing facility is registered with FDA and then continue due diligence with inspection history, product reporting, state licensure, and the relevant bulk-substance rules.
CheckProfiles should only be added when there is enough documentation to review.
A place for peptide profiles, human-study summaries, evidence grades, and notes on whether new research changes the picture.
Approved uses, controlled trials, endpoints, and safety limitations stay at the top.
Animal and cell findings should never read like human outcomes.
FDA, CMS, Medicare, and anti-doping posture should be tracked apart from benefit claims.
Adverse-event signals, compounding concerns, enforcement updates, and eligibility risk.
FDA and public-health notices affecting access, labeling, compounding, or enforcement.
WADA list changes and USADA enforcement related to peptide hormones and growth factors.
Known uncertainty and evidence gaps should sit beside news coverage, not below it.